Vertex Pharmaceuticals Corporation

Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.


Connections from

Total Funding: 656200000.0
Acquisitions Number: Made Acquisitions
Headquarters: Boston, Massachusetts, United States
Funding Status: IPO
Employee Number: 1001-5000
Estimated Revenue: $500M to $1B
Investment Stage: N/A
Last Funding Type: Post-IPO Equity
Number Of Exists: 2
Technology: Cancer
Investor Type: Company
Last Funding Date: 2022-05-17
Investors Number: 9.0
Founded Date: 1989-01-01
Industry: Pharma